dynalabs.us - DYNALABS investment doubles the size of its testing facility

DYNALABS investment doubles the size of its testing facility - DYNALABS

Dynalabs.us Spined HTML

DYNALABS investment doubles the size of its testing facility - DYNALABS 888.396.2522 314.241.3962 888.396.2522   •   314.241.3962   •   info@dynalabs.us LOGIN User Registration Account Registration  Menu Close Login User Registration Account Registration Products & Services Lab Services State-of-the-art tampering testing laboratory provides data you need to run your business. On Site Testing Less than 4 seconds to objectively verify drug identity and strength in your facility. CQI Program Use our expert knowledge of the pharmaceutical industry to help you grow your business. Continuous Quality Improvement (CQI) Consulting Services Customer Improvement System Customer Production System Data Analytics Laboratory Services Test Services Lab Services API (Active Pharmaceutical Ingredient ) list DVx™ On site Drug Verification DVx™ Specifications DVx™ Validation Process DVx™UnstipulatedFAQs On-site Managed Services Consulting Improvement Systems Production System Six Step Approach DYNALABS OOS Process Online Services Sample Submission Customer Service What We DoHospital Pharmacies Stability of Drug Diversion of Drug In House Training Product Validation Drug Investigation Compounding Pharmacies People: Training Validation Program Materials: Vendor Qualification Program Equipment: Performance Validation Program Process: Process Validation Program Product: Product Validation Program Frequently Asked Questions CompanyOur Story Announcements Announcing a new National Accounts Manager, Christine Versichele. DYNALABS announces new Chief Technology Officer DYNALABS welcomes a new Principal Consultant DYNALABS embarks on $1.2 million expansion DYNALABS Announces a New Vice President of Sales DYNALABS announces Director of Quality & Regulatory Affairs DYNALABS LLC Named One of Inc. 5000 Fastest-Growing Private Companies in 2017 DYNALABS named to the 50 Fastest Growing Companies of 2017 DYNALABS Enhances Antimicrobial Effectiveness Testing for USP Potency Testing for Oxytocin DYNALABS Announces New President DYNALABS investment doubles the size of its testing facility Custom Packing Slip DYNALABS Receives ISO/IEC 17025 Accreditation Entrepreneurial Success SmallMerchantryof the Year 2016 DYNALABS investment doubles the size of its testing facility Enforcing FDA Labeling Policies Entrepreneurial Success Award Events Registrations and Awards Vision, Mission Leadership Partners and Alliances Investor Information ResourcesWebinars Blogs Industry News FDA to Remove APIs from list FDA Drug Shortages The Pharma Reports The Pharma Report | Sept 2018 Tech Bulletin | June 2018 Tech Bulletin | May 2018 Tech Bulletin | April 2018 Tech Bulletin | March 2018 Tech Bulletin | February 2018 Tech Bulletin | January 2018 Tech Bulletin | December 2017 Careers Contact < Home | Company | Announcements | DYNALABS investment doubles the size of its testing facility DYNALABS investment doubles the size of its testing facility Steph Kukuljan Reporter St. LouisMerchantryJournal DYNALABS LLC, a St. Louis-based pharmaceuticals testing lab, spent $1.5 million to double the size of its testing facility, the visitor spoken Monday. Artisan Building Co. of St. Louis was the unstipulated contractor on the project, which widow a 15,500-square-foot second floor that features wet chemistry and tampering laboratories and an zone for glassware washing and drying. A lunch zone and priming space moreover was added. The facility, at 2327 Chouteau Ave., now is 33,500 square feet. “We examined DynaLabs’ space needs, re-evaluated the original drawings and wherever we saw a wall that wasn’t needed, we eliminated it,” Andy Barnes, principal at Artisan Building, said in the release. “That saved on electrical and mechanical infrastructure and moreover created increasingly opportunities for collaboration, rather than isolating each lab overdue walls.” DynaLabs COO and Managing Partner Russell Odegard said the visitor is planning increasingly renovations; work on its wipe room area, which provides a sterile environment for testing, is expected to start at the end of this year. No increasingly details were available. Liberty Electric Inc., American Mechanical and T.J. Wies Contracting Inc. moreover worked on the $1.5 million expansion. DynaLabs, founded in 2004, was one of the fastest growing companies in St. Louis in 2014. It saw revenue grow 124.07 percent from 2011 to 2013. DYNALABS LLC is registered with the U.S. Food and Drug Administration (FDA), DEA and Bureau of Narcotics and Dangerous Drugs licensed, as well as ISO 17025 accredited. The products and services provided by DYNALABS are protected by U.S. Patent Nos. 7,197,405 and 7,660,678. © 2018 DYNALABS LLC. All Rights Reserved. For spare information well-nigh DYNALABS please undeniability 888-396-2522   •   info@dynalabs.usTerms Of Use   •   Privacy Policy   •   Customer Agreement